Medication errors caused by confusion of drug names

Drug Safety

Volumn 26, Issue 7, 2003, Pages 445-452

  Hoffman, James M ^a   Proulx, Susan M ^b  

^a University of Wisconsin Health   (United States)

^b Med ERRS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ACETOHEXAMIDE; ALFENTANIL; ALTEPLASE; AMIODARONE; AMLODIPINE BESYLATE; AMRINONE; BETAXOLOL; CAFERGOT; CAPECITABINE; CARBOPLATIN; CEFOTETAN; CEFUROXIME AXETIL; CELECOXIB; CETIRIZINE; CILASTATIN PLUS IMIPENEM; CISPLATIN; CITALOPRAM; CITRATE CALCIUM; CONJUGATED ESTROGEN; DICYCLOVERINE; DOLASETRON MESILATE; DOXAZOSIN; FELODIPINE; FOLIC ACID; FOSINOPRIL; FOSPHENYTOIN SODIUM; FUROSEMIDE; GLIBENCLAMIDE; GLIPIZIDE; HYDROCODONE BITARTRATE PLUS PARACETAMOL; HYDROXYZINE; ISOSORBIDE 5 NITRATE; ISOSORBIDE DINITRATE; ISOTRETINOIN; KETOROLAC; LAMOTRIGINE; LANSOPRAZOLE; LEVOBUNOLOL; LISINOPRIL; LORACARBEF; LORAZEPAM; METHYLCELLULOSE; METHYLDOPA; METHYLPHENOBARBITAL; NALOXONE; NICARDIPINE; NORTRIPTYLINE; OLANZAPINE; OLOPATADINE; PACLITAXEL; PAROXETINE; POTASSIUM CHLORIDE; PROPRANOLOL; PROSTAGLANDIN E2; PSEUDOMONIC ACID; QUINAPRIL; RAMIPRIL; ROSIGLITAZONE; SUCRALFATE; SUFENTANIL CITRATE; TERBINAFINE; TETRAHYDROLIPSTATIN; THIORIDAZINE; TIOTIXENE; TORASEMIDE; UNINDEXED DRUG; VECURONIUM; VERAPAMIL; VERASAL; WARFARIN;

COMPUTER SYSTEM; CONFUSION; DRUG INDUSTRY; DRUG LEGISLATION; DRUG NOMENCLATURE; EUROPE; FOOD AND DRUG ADMINISTRATION; HEALTH CARE PERSONNEL; HUMAN; IATROGENIC DISEASE; MEDICATION ERROR; PATIENT; PATIENT EDUCATION; PHARMACIST; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; UNITED STATES; WORLD HEALTH ORGANIZATION; WRITING;

CLINICAL PHARMACY INFORMATION SYSTEMS; HUMANS; MEDICATION ERRORS; PHARMACEUTICAL PREPARATIONS; PROBLEM SOLVING; TERMINOLOGY; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0038578677     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200326070-00001     Document Type: Review

References (59)

1. Leape LL. A systems analysis approach to medical error. In: Cohen MR, editor. Medication errors. Washington, DC: American Pharmaceutical Association, 1999: 2.1-2.14
2. Kohn LT, Corrigan JM, Donaldson MS, editors. To err is human: building a safer health system. Washington, DC: National Academy Press, 1999
3. Williams E. Institute for Safe Medication Practices. Editorial response to pharmacist workload articles [online]. Available from URL: http://www.ismp.org/Pages/editorial.html [Accessed 2002 Mar 3]
4. Starr CH. When drug names spell trouble. Drug Topics 2000 May 15; 144 (10): 49-58
5. United States Pharmacopoeia Convention. Stop, look, and listen! United States Pharmacopoeia Qual Rev 1995; 49
6. Cohen MR. Drug product characteristics that foster drug-use-system errors. Am J Health Syst Pharm 1995; 52: 395-9
7. Lesar TS, Briceland L, Stein DS. Factors related to errors in medication prescribing. JAMA 1997 Jan 22; 277 (4): 312-7
8. Kenagy JW, Stein GC. Naming, labeling, and packaging of pharmaceuticals. Am J Health-Syst Pharm 2001; 58: 2033-41
9. Sentinel event alert: look-alike, sound-alike drug names [online]. Available from URL: http://www.jcaho.org/about +us/news+letters/sentinel+event+alert/sea_19.htm [Accessed 2002 Dec 13]
10. Sentinel events [online]. Available from URL: http://www.jcaho.org/about+us/news+letters/sentinel+event+alert/ perspectives+arficle.htm [Accessed 2002 Dec 14]
11. Davis NM, Cohen MR, Teplitsky B. Look-alike and sound-alike drug names: the problem and the solution. Hosp Pharm 1992 Feb: 27: 95-8, 102-5, 108-10
12. Aronson JK. Confusion over similar drug names problems and solutions. Drug Saf 1995; 12 (3): 155-60
13. Teplitsky B. Confusing names of drugs [letter]. JAMA 1969 Mar 31; 207 (13): 2440
14. Solomon KJ. Medication errors from similar trademarks [letter]. JAMA 1978 Mar 20; 239 (12): 1130
15. Wittaker RL. Confused drug names [letter]. Ann Intern Med 1980 Dec: 93 (6): 933
16. Huminer D, Dux S, Rosenfeld JB, et al. Inadvertent sulfonylurea-induced hypoglycemia: a dangerous, but preventable condition. Arch Intern Med 1989 Aug; 149: 1890-2
17. Shumak SL, Corenblum B, Steiner G. Recurrent hypoglycemia secondary to drug-dispensing error. Arch Intern Med 1991 Sep; 151: 1877-8
18. Fine SN, Eisdorfer RM, Miskovitz PF, et al. Losec or Lasix [letter]. N Engl J Med 1990 Jun 7; 322: 1674
19. Hooper PL, Tello RJ, Burstein PJ, et al. Pseudoinsulinoma: the Diamox-Diabinese switch [letter]. N Engl J Med 1990 Aug 16; 323: 488
20. Hoffman JP. More on 'Losec or Lasix' [letter]. N Engl J Med 1990 Nov 15; 323: 1428
21. Kurth MC, Langston JW, Tetrud JW. "Stelazine" versus "Selegiline": a hazard in prescription writing [letter]. N Engl J Med 1990 Dec 20; 323: 1776
22. Huseby JS, Anderson P. Confusion about drug names. N Engl J Med 1991 Aug 22; 325 (8): 588-9
23. Fraterrigo CC, Frangella GM. The "Z" word [letter]. Am J Hosp Pharm 1994 Jan 15; 51: 235
24. Anon. Confusion of drug names signalled [letter]. CMAJ 1995 Jun 1; 152 (11): 1749
25. Costable JM, McKinley MJ. Prozac or prilosec for gastric ulcer [letter]. N Engl J Med 1996 Aug 22; 335 (8): 600
26. Teplitsky B. Caution: 1000 drugs whose names look or sound alike. Pharm Times 1978 Jan; 44: 41-3
27. McNulty H, Spurr P. Drug names that look or sound alike [letter]. BMJ 1979 Oct 6; 2 (6194): 836
28. Davis NM. Drug names that look and sound alike. Hosp Pharm 1999; 34: 1160-2, 1164-6, 1169-70, 1173-4, 1177-8
29. Lambert BL, Chang KY, Lin SJ. Effect of orthographic and phonological similarity on false recognition of drug names. Soc Sci Med 2001; 52: 1843-57
30. Boring D. More names. Mod Drug Discov 2000 Oct; 3 (8): 35-6
31. Boring D. The development and adoption of nonproprietary, established, and proprietary names for pharmaceuticals. Drug Inf J 1997; 31: 621-34
32. Boring DL. The CDER labeling and nomenclature committee: Structure, function, and process. Drug Inf J 1997; 31: 7-11
33. World Health Organization. International nonproprietary names: revised procedure [online]. Available from URL: http://www.who.int/gb/EB_WHA/PDF/EB110/eeb1103.pdf [Accessed 2003 Mar 19]
34. Friedmanis R. editor. USAN Handbook, 5th ed. Chicago (IL); American Medical Association, 1999
35. British Pharmacopoeia. British approved names [online]. Available from URL: http://www.pharmacopoeia.org.uk/british.cfm [Accessed 2003 Mar 19]
36. British Pharmacopoeia. British approved names: guiding principles [online]. Available from URL: http://www.pharmacopoeia.org.uk/guiding.cfm [Accessed 2003 Mar 19]
37. Fleeger CA, editor. USP dictionary of USAN and international drug names. Rockville (MD); US Pharmacopeia, 1997
38. Cohen MR, DiDomizio G. Key challenges in global branding. World Markets Series: Healthcare and Pharmaceutical Briefing. 2000: 28-30
39. Zoeller J. Searle weighs Celebrex name change: new cox-2 has been confused with other similarly-named drugs. Am Druggist 1999 May; 216 (5): 15
40. Dispensing errors alert [online]. Available from URL: http://www.fda.gov/medwatch/safety/2000/lamict.htm [Accessed 2002 Mar 3]
41. Smetzer J, Cohen MR, editors. Safety briefs. Institute for Safe Medication Practices (ISMP) Medication Safety Alert 1999 Oct 6; 4 (20): 1-3
42. Smetzer J, Cohen MR, editors. Safety Briefs. Institute for Safe Medication Practices (ISMP) Medication Safety Alert 1999 Sept 8; 4 (18): 1
43. Mitka M. What's in a (drug) name? plenty! JAMA 1999 Oct 20; 282 (15): 1409-10
44. Amrinone to become inamrinone based upon USP Nomenclature Committee and USAN council decisions. Available from URL: http://www.usp.org/aboutusp/releases/2000/pr_ 2000-05.htm [Accessed 2002 Mar 03]
45. Cohen MR, Anderson RW, Attilio RM, et al. Preventing medication errors in cancer chemotherapy. Am J Health Syst Pharm 1996; 53: 737-46
46. Mahmud A, Holquist C, Phillips J. Stemming drug errors from abbreviations [online]. Available from URL: http://www.fda.gov/cder/drug/mederrors/nameAbbreviations.pdf. [Accessed 2002 Dec 16]
47. Schwab M, Oetzel C, Morike K, et al. Using trade names: a risk factor for accidental drug overdose. Arch Intern Med 2002; 162: 1065-6
48. Phillips J. The name game: new realities at FDA. Pharm Executive 2000 Jul, 9
49. Holquist C, Phillips J. How FDA reviews drug names [online]. Available from URL: http://www.fda.gov/cder/drug/MedErrors/reviewDrugNames.pdf [Accessed 2002 Dec 15]
50. Palmer C. OPDRA Consult #00-0046 [online]. Available from URL: http://www.fda.gov/cder/drug/infopage/unithroid/optrare.pdf [Accessed 2002 Dec 16]
51. Committee for Proprietary Medicinal Products (CPMP). Revised guidance paper on the acceptability of tradenames for human medicinal products processed through the centralised procedure [online]. Available from URL: http://www.emea.eu.int/pdfs/human/regaffair/032898en.pdf [accessed 2002 Mar 03]
52. Lambert BL. Predicting look- and sound-alike medication errors. Am J Health Syst Pharm 1997; 54: 1161-71
53. Lambert BL, Lin S-J, Gandhi SK, et al. Similarity as a risk factor in drug name confusion errors: the look-alike (orthographic) and sound-alike (phonological) model. Med Care 1999; 37: 1214-25
54. Cohen MR. Preventing medication errors related to prescribing. In: Cohen MR, editor. Medication errors. Washington, DC: American Pharmaceutical Association, 1999: 8.1-8.23
55. Bates DW, Leape LL, Cullen DJ, et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA 1998; 280: 1311-6
56. Bates DW, Teich JM, Lee J, et al. The impact of computerized physician order entry on medication error prevention. JAMA 1999; 6: 313-21
57. Institute for Safe Medication Practices (ISMP). A call to action: eliminate handwritten prescriptions within 3 years. Huntingdon Hall (PA), 2000 Apr
58. Schiff GD, Rucker D. Computerized prescribing: building the electronic infrastructure for better medication usage. JAMA 1998; 279: 1024-9
59. Leape LL, Berwick DM, Bates DW. What practices will most improve safety? Evidence-based medicine meets patient safety. JAMA 2002; 288: 501-7